Penumbra, Inc.

Penumbra, Inc. designs, develops, manufactures, and markets medical devices globally, focusing on computer-assisted vacuum thrombectomy. Its portfolio includes the Indigo System for power aspiration of thrombus, Lightning Flash mechanical thrombectomy system, and Lightning Bolt 7 arterial thrombectomy system. For neurovascular procedures, it offers the Penumbra System with reperfusion catheters and separators, the 3D Revascularization device, and neuro embolization coiling systems like Penumbra Coil 400 and SMART COIL. Peripheral embolization products include the Ruby Embolization Platform and POD System. Access products feature guide catheters under brands like Neuron, MAX, and BENCHMARK. The company also provides the Penumbra ENGINE aspiration pump and various accessories.

Penumbra, Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol PEN. Its shares are traded in US Dollars (USD), reflecting its primary listing in the United States. The company is headquartered in the United States and its stock is available for trading on the NYSE, a major US exchange.

Penumbra, Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. The company focuses on developing innovative medical technologies for vascular and neurovascular conditions. Its products are used in procedures such as thrombectomy (removal of blood clots) and embolization (blocking blood vessels), serving both peripheral and neurovascular applications. As a medical device company, Penumbra designs and manufactures tools used by healthcare professionals in hospitals and clinics worldwide.

Penumbra, Inc. is headquartered in the United States and serves markets both domestically and globally. The company designs, develops, manufactures, and markets its medical devices in the United States and internationally. Its products are used in hospitals and medical facilities around the world, with a focus on thrombectomy and embolization procedures. While specific headquarters city is not provided, the company's operations span across multiple regions, leveraging its US base to distribute products globally.

Penumbra generates revenue by designing, manufacturing, and selling medical devices for vascular and neurovascular procedures. Its portfolio is divided into several key areas: computer-assisted vacuum thrombectomy (e.g., Indigo System, Lightning Flash), neurovascular thrombectomy (Penumbra System, 3D Revascularization device), neuro embolization coiling (Penumbra Coil 400, SMART COIL), peripheral embolization (Ruby Embolization Platform, POD System), and access products (guide catheters under Neuron, MAX, BENCHMARK brands). The company also sells aspiration pumps (Penumbra ENGINE) and various accessories. Revenue comes from direct sales to hospitals and healthcare providers, as well as through distribution channels in the US and international markets.